The winding path of Illumina/Grail

The European Commission’s decision to prohibit Illumina’s already-completed acquisition of Grail brought an end to the administrative stage of a legal saga that has attracted interest beyond competition law specialists. Norton Rose Fulbright partner Miranda Cole examines the case’s highly-debated implications for the EU merger control regime in light of both the commission’s ruling and the EU General Court’s remarks on the matter so far.

Unlock unlimited access to all Global Competition Review content